The MFN1 Knockout Raji Polyclonal Cells constitute a CRISPR/Cas9-mediated knockout cell population targeting the MFN1 gene in Raji cells. This polyclonal pool, generated by gene disruption via CRISPR/Cas9, provides a heterogeneous collection of edited cells for studying MFN1 loss-of-function. The host Raji cell line, a human B lymphocyte derived from Burkitt’s lymphoma, offers a well-characterized model for immunology and cancer research. The knockout product format enables researchers to investigate mitochondrial dynamics without clonal selection.
Raji cells are Epstein-Barr virus positive lymphoblastoid cells widely employed in studies of immunoglobulin production, antigen presentation, and adaptive immune responses. Their origin from a highly proliferative B-cell lymphoma makes them particularly relevant for examining oncogenic metabolic rewiring and apoptotic evasion mechanisms. The lymphoblastoid background supports robust growth in suspension culture suitable for high-throughput screening and biochemical assays.
MFN1 encodes a dynamin-like GTPase essential for mitochondrial outer membrane fusion, functioning in concert with MFN2 and OPA1 to maintain mitochondrial network integrity. It is regulated by PGC-1?? transcriptional control and post-translational modifications including ubiquitination by Parkin and MARCH5, with PINK1-mediated signaling also influencing its activity. MFN1 opposes the fission-promoting protein DRP1 and interacts with BAX/BAK to modulate cytochrome c release and apoptosis. Downstream consequences of MFN1 disruption include fragmented mitochondrial morphology, reduced ATP production, and altered calcium signaling, collectively impacting oxidative phosphorylation and mitophagy.
In the Raji model, MFN1 knockout likely perturbs mitochondrial homeostasis critical for supporting the high metabolic demand of lymphoma cells. Since Raji cells rely on mitochondrial function for survival and proliferation, loss of MFN1-mediated fusion may sensitize them to apoptotic stimuli and disrupt energy metabolism. This is particularly relevant given the role of mitochondrial dynamics in cancer cell adaptation and the EBV-driven transformation background of Raji cells.
This polyclonal knockout population enables detailed investigation of mitochondrial dynamics, apoptosis, and cancer metabolism. Standard assays include western blotting for MFN1 to confirm protein loss, immunofluorescence microscopy of TOM20 for mitochondrial morphology, JC-1 flow cytometry for membrane potential, Annexin V apoptosis assays, ATP quantification, and Seahorse respirometry for oxygen consumption rate. Applications span neurodegenerative disease modeling, drug screening for mitochondrial dysfunction, and mechanistic dissection of Parkin/PINK1-mediated mitophagy. For further information, please contact Ascent Research.
